In-situ gel: a study of dental diseases
Keywords:
In-situ Dental Gel, Periodental diseases, Gingivitis, PeriodontitisAbstract
In-situ forming polymeric gelling systems has become prominent among novel drug delivery system (NDDS) in recent years due to advantages such as sustained and prolonged drug action, improved patient compliance and reduced frequency of administration of the drug in comparison to conventional drug delivery system (DDS). This is a type of mucoadhesive DDS where the polymeric formulation is in sol form before administration and once comes in contact with body fluids; it undergoes gelation to form a gel. The formulation of gel depends upon factors like temperature modulation, pH changes, presence of ions and ultraviolet irradiation from which drug gets released in sustained and controlled manner. Conventional formulation for the treatment of dental diseases has certain drawbacks. A new concept of in situ gel was develop to overcome the shortcoming of conventional formulation which deals with dental diseases. Conventional oral formulations like solution, suspension, and ointments have many disadvantages which result into poor bioavailability of drug in the buccal cavity. In-situ forming polymeric formulation drug delivery systems is in sol form before administration in the body, but once administered, undergoes gelation in-situ to form a gel.
Downloads
References
Neha NM, Kishore NG. Orodental Delivery System. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5: 1-83.
Morrison HI, Ellison LF, Taylor GW et al. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk. 1999; 6: 7-11.
Ramya DD, Abhirami M, Brindha R, et al. In-situ Gelling System – Potential Tool for Improving Therapeutic Effects of Drugs. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5: 27-29.
Sarika SS, HK Kunjwani, Jayashree VK, et al. Novel Polymeric in Situ Gels for Ophthalmic Drug Delivery System. International Journal of Research in Pharmacy and Science. 2012; 2: 67-83.
Divya K, Nidhi J, Neha G, et al. Nanoparticles laden in situ gelling system for oculardrug targeting. Journal of Advanced Pharmaceutical Technology & Research. 2013; 4: 9-15.
Upendra N, Nidhi J, Divya K, et al. Controlled ocular drug delivery of ofloxacinn using temperature modulated in situ gelling system. Journal of the Scientific Society. 2013; 40: 90-94.
Nanjawade BK, Manvi FV, Manjappa AS. In situ‑forming hydrogels for sustained ophthalmic drug delivery. J Control Release. 2007; 122: 119‑34.
NV Sathesh M, Ashok KS, Pragati S, et al. Orotransmucosal Drug Delivery System: A review. J Controlled Release. 2009: 2-11.
Priyanka B, Yogesh SC, Suresh K, et al. An Overview On Treatment Of Periodontal Disease. Asian Journal of Pharmacy and Medical Science. 2013; 3: 33-34.
Shankraiah M, Nagesh C, Venkatesh JS, et al. Sustained Release Device Containing Ornidazole For Periodontitis. International Research Journal Of Pharmacy. 2011; 2: 217-21.
Abdellaoui KS, Castioni NV, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. European Journal of Pharmaceutics and Biopharmaceutics. 2000: 83-93.
Sakshi A, Vidya D, Bhavna JK, et al. A comparative evaluation of efficacy of Punicagranatum and chlorhexidine on plaque and gingivitis. Journal of the International Clinical Dental Research Organization. 2011; 3: 29-32.
Pragati S, Ashok S, Kuldeep S. Recent Advances in Periodpontal Drug Delivery Systems. International Journal of Drug Delivery. 2009; 1: 1-14.
Tapash KG, William RPF. Drug Delivery to the oral Cavity, Molecule to Market, Drugs and the Pharmaceutical sciences. Taylor and Francis group. New York. 2005; 145: 211-30.
Pratik P, Ankur J, AK Sheth. Formulation and Evaluation of Sustained Release Chlorhexidine In Situ Gel for Periodontitis. An International Journal of Pharmaceutical Sciences. 2013; 4: 465-78.
Varun R et al. A Brief Review on Oral Film Technology. International Journal of Research in Ayurveda and Pharmacy. 2011; 2: 1138-47.
Patel PB, Shastri DH, Shelat PK, Shukla K. Devlopment And Evaluation Of phTrigerred In Situ Opthalmic In Situ Gel Formulation Of Ofloxacin. Am.J.Pharmatech.R. 2011; 2: 431-45.
Kushal P, Piyush A, Ashok D, et al. Formulation and Evaluation of Oral Floatable In-situ Gel of Ranitidine Hydrochloride. Journal of Drug Delivery & Therapeutics. 2013; 3: 90-97.
Kulwant S, SL Hari K. Injectable In-situ Gelling Controlled Release Drug Delivery System. International Journal of Drug Development & Research. 2012; 4: 56-69.
Ravivarapu HB, Moyer KL, Dunn RL. Sustained Activity and Release of Leuprolide Acetate from an In-situ Forming Polymeric Implant. Pharm Sci Tech. 2000; 1: 216-24.
Kashyap N, Viswanad B, Sharma G, et al. Design and evaluation of biodegradable, biosensitive in situ gelling systems for pulsatile delivery of insulin. Biomaterials. 2007; 28: 2051-60.
Marie S. In Situ Gelling Drug Delivery Systems for Periodontal Anaesthesia. Acta Universitatis Upsaliensis. 2000: 1-53.
Sumegha M, Surendra KJ, Nishiprakash J. Formulation And Evalution Of Formulation And Evaluation Of In Situ Ophthalmic Gel Of Ketorolac Tromethamine. W.J.P.P.S. 2013; 2: 1370-84.
Miyazaki S, Suisha F, Kawasaki N. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J Control Rel. 1998; 56: 75–83.
Anderson BC, Pandit NK, Mallapragada SK. Understanding drug release from poly (ethylene oxide)-b-(propylene oxide)-b-poly(ethylene oxide) gels. J Control Release. 2001; 70: 157–67.
Moore T, Croy S, Mallapragada SK, et al. Experimental investigation and mathematical modelling of Pluromic F127 gel dissolution drug release in stirred systems. J Control Release. 2000; 67: 191–02.
Kute JU, Darekar AB, Saudagar RB. In Situ Gel-Noval Approach for Nasal Delivery. World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 3: 187-03.
Aman K, Suchetha R, Shankraiah MM, et al. In Situ Gelling System - An Overview. Pharmacologyonline. 2011; 2: 28-44.
Jeong B, Gutowska A. Lessons from nature: stimuli responsive polymers and their biomedical applications. Trends Biotechnol. 2002; 20: 305–11.
Hoffman AS, Afrassiabi A, Dong LC. Thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions. J Control Release. 1986; 4: 213–22.
Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: New trends in Controlled and Sustained Drug Delivery System. International Journal of Pharm Tech Research. 2010; 2: 1398-1408.
Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2001; 53: 321-39.
Soppimath KS, Aminabhavi TM, Dave AM, et al. Stimulus-responsive “smart” hydrogels as novel drug delivery systems. Drug Dev Ind Pharm. 2002; 28: 957-74.
Bheskaran S, Lakshmi PK, Harish CG. Topical ocular drug delivery: a review. Indian Journal of Pharmaceutical Sciences. 2005; 64: 404–408.
Guo J-H, Skinner GW, Harcum WW, et al. Pharmaceutical applications of naturally occurring water-soluble polymers. Pharm Sci & Technol Today. 1998; 1: 254-61.
Podual K, Doyle III FJ, Peppas NA. Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene)- grafted cationic hydrogels in an environment changing Ph. Biomaterials. 2000; 21: 1439-50.
Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: New trends in Controlled and Sustained Drug Delivery System. International Journal of Pharm Tech Research. 2010; 2: 1398-1408.
Dhirajkumar KC, Sushilkumar SP. Current Status of Ophthalmic In-situ Forming Hydrogel. International Journal of Pharma and Bio Sciences. 2012; 3: 372-388.
Published
How to Cite
Issue
Section
Copyright (c) 2020 Neha Bisht, Laxmi Goswami, Preeti Kothiyal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
